These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 19780621)

  • 1. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
    Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
    Melchart M; Habtemariam A; Parsons S; Sadler PJ
    J Inorg Biochem; 2007 Nov; 101(11-12):1903-12. PubMed ID: 17582501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
    Habtemariam A; Melchart M; Fernandez R; Parsons S; Oswald ID; Parkin A; Fabbiani FP; Davidson JE; Dawson A; Aird RE; Jodrell DI; Sadler PJ
    J Med Chem; 2006 Nov; 49(23):6858-68. PubMed ID: 17154516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
    Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
    Peacock AF; Parsons S; Sadler PJ
    J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
    Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifunctional amine-tethered ruthenium(II) arene complexes form monofunctional adducts on DNA.
    Melchart M; Habtemariam A; Novakova O; Moggach SA; Fabbiani FP; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2007 Oct; 46(21):8950-62. PubMed ID: 17850143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.
    Wang F; Chen H; Parsons S; Oswald ID; Davidson JE; Sadler PJ
    Chemistry; 2003 Dec; 9(23):5810-20. PubMed ID: 14673852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
    Grgurić-Sipka S; Ivanović I; Rakić G; Todorović N; Gligorijević N; Radulović S; Arion VB; Keppler BK; Tesić ZLj
    Eur J Med Chem; 2010 Mar; 45(3):1051-8. PubMed ID: 20053483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
    van Rijt SH; Peacock AF; Johnstone RD; Parsons S; Sadler PJ
    Inorg Chem; 2009 Feb; 48(4):1753-62. PubMed ID: 19146436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The remarkable reactivity of high oxidation state ruthenium and osmium polypyridyl complexes.
    Meyer TJ; Huynh MH
    Inorg Chem; 2003 Dec; 42(25):8140-60. PubMed ID: 14658865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
    Bíró L; Farkas E; Buglyó P
    Dalton Trans; 2012 Jan; 41(1):285-91. PubMed ID: 22051630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmium(II) and ruthenium(II) arene maltolato complexes: rapid hydrolysis and nucleobase binding.
    Peacock AF; Melchart M; Deeth RJ; Habtemariam A; Parsons S; Sadler PJ
    Chemistry; 2007; 13(9):2601-13. PubMed ID: 17200926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands.
    Marchetti F; Pettinari C; Cerquetella A; Cingolani A; Pettinari R; Monari M; Wanke R; Kuznetsov ML; Pombeiro AJ
    Inorg Chem; 2009 Jul; 48(13):6096-108. PubMed ID: 19507885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.